Nature is the most advanced R&D lab in the universe. At PPM, we work to apply existing methods and invent new technologies inspired by phytosynthesis processes in the plant. We are also fully engaged with whole plant and entourage effect research and its application to improve health.

PPM coined the term Cannamimetic™ to describe naturally inspired ways to access the important bioactive, “minor” cannabinoids that currently manifest in existing hemp cultivars in de minimis concentrations. More effective plant-based extracts and concentrates can be formulated with these cannabinoids. PPM customized an existing scientific term, biomimetic, which means copying biochemical processes in Nature.

Cannamimetics™ simply means following Mother Nature’s lead. It is well known and extensively researched that during a hemp plant’s growth, various enzymatic, oxidation, photochemical and other bioprocesses produce cannabinoids and other bioactive compounds, transforming them during the course of the plant’s growth cycle.

As CBN, CBG, CBC, CBD, THCV, CBV, CBDV, CBDA, and other non-psychotropic cannabinoids (and terpenoids, flavonoids, and polyphenols) are genetically bred to express in greater potencies in new hemp cultivars and recognized for their therapeutic benefits, PPM will be at the forefront of separating, isolating, refining, and purifying these molecules and creating novel ratios, as well as whole plant combinations (and THC-free versions) to meet market demand.

The most effective bespoke and whole plant entourage effects remain the ultimate goal in everything we do. We are confident our efforts will continue to yield more effective and improved plant-based products to bring better health to all.